Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants.
Saved in:
| Title: | Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. |
|---|---|
| Authors: | Luo R; Crinetics Pharmaceuticals, San Diego, CA, USA., Madan A; Crinetics Pharmaceuticals, San Diego, CA, USA., Ferrara-Cook CT; Crinetics Pharmaceuticals, San Diego, CA, USA., Dalvie D; Crinetics Pharmaceuticals, San Diego, CA, USA., Goulet L; Crinetics Pharmaceuticals, San Diego, CA, USA., Struthers RS; Crinetics Pharmaceuticals, San Diego, CA, USA., Krasner AS; Crinetics Pharmaceuticals, San Diego, CA, USA. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2025 Jul; Vol. 91 (7), pp. 2070-2079. Date of Electronic Publication: 2025 Mar 05. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
